(Q51990381)

19 April 2018

title

CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells. (English)

1 reference

19 April 2018

1 reference

3

1 reference

19 April 2018

Gunther Hartmann

12

1 reference

19 April 2018

Andreas Greinacher

9

object named as

Andreas Greinacher

1 reference

19 April 2018

11

Stefan Endres

1 reference

19 April 2018

author name string

Anja Marschner

1

1 reference

19 April 2018

Simon Rothenfusser

2

1 reference

19 April 2018

Domenik Prell

4

1 reference

19 April 2018

Anne Krug

5

1 reference

19 April 2018

Miren Kerkmann

6

1 reference

19 April 2018

Daniela Wellisch

7

1 reference

19 April 2018

Hendrik Poeck

8

1 reference

19 April 2018

Thomas Giese

10

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 August 2005

1 reference

19 April 2018

European Journal of Immunology

published in

1 reference

19 April 2018

volume

35

1 reference

19 April 2018

issue

8

1 reference

19 April 2018

page(s)

2347-2357

1 reference

19 April 2018

Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Costimulation of CD8 T cell responses by OX40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

CD1: antigen presentation and T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

NK cells and NKT cells in innate defense against viral infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

[Development of KRN7000, derived from agelasphin produced by Okinawan sponge]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG motifs: the active ingredient in bacterial extracts?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200425721

1 reference

7 January 2021

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Plasmacytoid dendritic cells: the key to CpG.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

CpG oligodeoxynucleotides as vaccine adjuvants in primates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Use of CpG oligodeoxynucleotides as immune adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

T-cell proliferation in vivo and the role of cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425721

7 January 2021

Identifiers

DOI

10.1002/EJI.200425721

1 reference

19 April 2018

1 reference

19 April 2018